Inozyme Pharma, Inc. - Common Stock (NQ:INZY)

4.000 UNCHANGED

Last Price Updated: 4:00 PM EDT, Jun 30, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Inozyme Pharma, Inc. - Common Stock

< Previous 1 2 3 4 Next >

Gold Down Over 1%; Flowers Foods Posts Weak Earnings ↗

May 16, 2025

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

May 16, 2025

Via Benzinga

Inozyme Stock Rockets 179% After BioMarin Agrees To Acquire The Company For $270M: Retail Sentiment Brightens ↗

May 16, 2025

The deal's per-share price consideration implies an 182% premium to Inozyme’s closing price of $1.42 on Thursday.

Via Stocktwits

US Stocks Edge Higher; Consumer Sentiment Falls In May ↗

May 16, 2025

Via Benzinga

Inozyme Pharma: Q4 Earnings Insights ↗

March 12, 2024

Via Benzinga

6 Analysts Have This to Say About Inozyme Pharma ↗

September 27, 2023

Via Benzinga

Analyst Expectations for Inozyme Pharma's Future ↗

September 08, 2023

Via Benzinga

4 Analysts Have This to Say About Inozyme Pharma ↗

August 09, 2023

Via Benzinga

BioMarin Bolsters Pipeline With $270 Million Inozyme Pharma Takeover ↗

May 16, 2025

Inozyme Pharma is working on an enzyme replacement therapy for ENPP1 deficiency in children.

Via Investor's Business Daily

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

May 16, 2025

Via Benzinga

Why Analyst Says Rare Disease-Focused Inozyme Pharma Stock 'Could Be Worth A Look' ↗

September 12, 2024

Stifel initiates coverage on Inozyme Pharma with a Buy rating and a $16 price target, highlighting INZ-701's potential to treat rare diseases like ENPP1 and ABCC6 deficiencies.

Via Benzinga

This AutoNation Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday ↗

September 12, 2024

Via Benzinga

Why Nikola Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

August 19, 2024

Via Benzinga

Analyst Ratings for Inozyme Pharma ↗

April 19, 2023

Via Benzinga

ZIM Integrated Shipping Services Posts Upbeat Earnings, Joins fuboTV, Foghorn Therapeutics And Other Big Stocks Moving Higher On Monday ↗

August 19, 2024

Via Benzinga

INZY Stock Earnings: Inozyme Pharma Misses EPS for Q2 2024 ↗

August 06, 2024

INZY stock results show that Inozyme Pharma missed analyst estimates for earnings per share the second quarter of 2024.

Via InvestorPlace

INZY Stock Earnings: Inozyme Pharma Misses EPS for Q1 2024 ↗

May 07, 2024

INZY stock results show that Inozyme Pharma missed analyst estimates for earnings per share the first quarter of 2024.

Via InvestorPlace

12 Health Care Stocks Moving In Monday's After-Market Session ↗

April 29, 2024

Via Benzinga

Top 5 Health Care Stocks That May Plunge In March ↗

March 28, 2024

As of March 28, 2024, five stocks in the health care sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.

Via Benzinga

Why Tilray Brands Shares Are Trading Lower By Around 22%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

April 09, 2024

Shares of Tilray Brands, Inc. (NASDAQ: TLRY) fell sharply during Tuesday’s session after the company missed third-quarter estimates and said it no longer expects to generate positive adjusted free

Via Benzinga

Inozyme Pharma Posts Encouraging Data From Rare Calcification Disorders ↗

September 26, 2023

Inozyme Pharma Inc (NASDAQ: INZY) announced interim safety, pharmacokinetic (PK), pharmacodynamic (PD), and exploratory efficacy data from its ongoing Phase 1/2 trials of INZ-701 in adults with

Via Benzinga

12 Health Care Stocks Moving In Monday's After-Market Session ↗

September 25, 2023

Via Benzinga

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

July 27, 2023

Via Benzinga

Inozyme Outlines Plans For Pediatric Trial For ENPP1 Deficiency Treatment: Targets 2026 Commercial Launch For INZ-701 ↗

July 26, 2023

Following meetings with the FDA and the European Medicines Agency's Paediatric Committee, Inozyme Pharma Inc (NASDAQ: INZY) updated its global development strategy for INZ-701, a

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

July 26, 2023

Via Benzinga

Recap: Inozyme Pharma Q1 Earnings ↗

May 09, 2023

Inozyme Pharma (NASDAQ:INZY) reported its Q1 earnings results on Tuesday, May 9, 2023 at 08:30 AM. Here's what investors need to know about the announcement. Earnings Inozyme Pharma beat estimated...

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

April 06, 2023

Via Benzinga

Why Y-mAbs Therapeutics Shares Are Trading Higher By 50%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗

March 31, 2023

Gainers Y-mAbs Therapeutics, Inc (NASDAQ: YMAB) climbed 49.9% to $4.93 after the company posted a profit for the fourth quarter.

Via Benzinga

Around $1.5M Bet On This Healthcare Stock? Check Out These 4 Penny Stocks Insiders Are Aggressively Buying ↗

March 31, 2023

The Dow Jones closed higher by more than 100 points on Thursday. When insiders purchase or sell shares, it indicates their confidence or ...

Via Benzinga

Why Safe & Green Holdings Shares Are Trading Higher By 30%; Here Are 20 Stocks Moving Premarket ↗

March 30, 2023

Gainers Boxed, Inc. (NYSE: BOXD) gained 43.3% to $0.2303 in pre-market trading after declining 6% on Wednesday. Boxed recently said it is evaluating potentially filing for relief under the U.S....

Via Benzinga

< Previous 1 2 3 4 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.